Using CBD to tame a cannabis high? Small doses may have opposite effect Bailey Rahn February 28, 2019 Share Print (imaginima/iStock) Take some CBD, they said. You’ll feel less high, they said. This common piece of advice fed to THC-shy consumers can effectively bring someone back down to earth. It works—sometimes. But new research shows there’s likely more nuance in the solution than we initially thought. Scientists found that a high dose of CBD dampened the effects of a THC high, but participants reported a stronger high when combined with low doses of CBD. CBD can either dampen an out-of-control high [...]
Lire la suiteMarijuana Use Linked to Stroke, Arrhythmia in Young People Sue Hughes Medscape - Nov 12, 2019 https://www.medscape.com/viewarticle/921116?nlid=132614_2052&src=WNL_mdplsnews_191115_mscpedit_psyc&uac=292598PZ&spon=12&impID=2168195&faf=1019 Use of marijuana is linked to a higher risk of stroke and hospitalization for cardiac arrhythmia in young people, two new studies suggest. Both studies will be presented at this weekend's American Heart Association (AHA) Scientific Sessions 2019 in Philadelphia. In the observational stroke study, young adults with recent marijuana use had almost twice the risk compared with non-users of having had a stroke, and the risk increased further among frequent marijuana users. The risk of having had a stroke was even higher — three times that of non-users — in frequent [...]
Lire la suiteLong-Term Pot Smoking Doesn’t Seem to Harm Health : Study Mandy Oaklander, The TIME, june 7, 2016 https://time.com/4359757/pot-smoking-marijuana-cannabis-health/?fbclid=IwAR1KRAo13u_0iDCYsWwYDd7_HwwFSRX8wkBQcWtgq1VneRwAfmdQwCY2Gw0 Getty Images By Mandy Oaklander June 7, 2016 Even after years of heavy use, marijuana doesn’t seem to have much of an impact on the physical health of the body. So finds a recent study published in JAMA Psychiatry, which analyzed data from a group of 1,037 New Zealanders followed from their birth until age 38. The researchers, led by Madeline Meier of Arizona State University, looked at whether cannabis use from age 18 to 38 was linked to several aspects of physical health, which were measured at [...]
Lire la suiteSelf-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users M.O. Bonn-Miller, M.T. Boden, M.M. Bucossi, K.A. Babson The American Journal of Drug and Alcohol Abuse, 2014, 40, (1), 23-30. doi : 10.3109/00952990.2013.821477. OBJECTIVES Little research has investigated the demographic and symptom profile of medical cannabis users in states in the USA that have legalized cannabis use. METHODS In the present cross-sectional study, we investigated the demographic profile of 217 adults currently receiving medical cannabis, as well as differences in problematic use and perceived helpfulness in terms of (i) symptoms of psychological disorders and pain, and (ii) motives for use. RESULTS Findings indicated that medical cannabis users (i) [...]
Lire la suiteUS Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws 1991-1992 to 2012-2013 Deborah S. Hasin, Aaron L. Sarvet, Magdalena Cerda, Katherine M. Keyes, Malka Stohl, Sandro Galea, Melanie M. Wall JAMA Psychiatry, 2017, 74, (6), 579–610. Doi : 10.1001/jamapsychiatry.2017.0724 PMCID: PMC5539836 PMID: 28445557 Key Points Question Are US state medical marijuana laws one of the underlying factors for increases in risk for adult cannabis use and cannabis use disorders seen since the early 1990s? Findings In this analysis using US national survey data collected in 1991-1992, 2001-2002, and 2012-2013 from 118 497 participants, the risk for cannabis use and cannabis use disorders increased at a significantly [...]
Lire la suiteCannabis use, pain and prescription opioid use in people living with chronic non-cancer pain : Findings from a four-year prospective cohort Gabrielle Campbell, Wayne D. Hall, Amy Peacock, Nicholas Lintzeris, Raimondo Bruno, Briony Larance, Suzanne Nielsen, Milton Cohen, Gary Chan, Richard P. Mattick, Fiona Blyth, Marian Shanahan, Timothy Dobbins, Michael Farrell, Louisa Degenhardt Lancet Public Health, 2018, 3, (7): e341–e350. doi:10.1016/S2468-2667(18)30110-5. Abstract Background : There has been growing interest in the use of cannabis and cannabinoids to treat chronic non-cancer pain (CNCP). Cannabis and cannabinoids have attracted attention because of their greater safety compared with opioids, and the possibility that their use can reduce opioid [...]
Lire la suiteThe effect of cannabis laws on opioid use. J.L. Flexon, L. Stolzenberg, S.J. d'Alessio International Journal of Drug Policy, 2019, 74, 152-159. doi : 10.1016/j.drugpo.2019.09.013. Abstract BACKGROUND : Many Americans rely on opioids at varying dosages to help ameliorate their suffering. However, empirical evidence is mounting that opioids are ineffective at controlling non-cancer related chronic pain, and many argue the strategies meant to relieve patient suffering are contributing to the growing opioid epidemic. Concurrently, several states now allow the use of medical cannabis to treat a variety of medical conditions, including chronic pain. Needing more exploration is the impact of cannabis laws on general opioid reliance [...]
Lire la suiteNotes from the Field : Acute Poisonings from a Synthetic Cannabinoid Sold as Cannabidiol — Utah, 2017–2018 Roberta Z. Horth, Barbara Crouch, B. Zane Horowitz, Amelia Prebish, Matthew Slawson, Jennifer McNair, Chris Elsholz, Stephen Gilley, Jenny Robertson, Ilene Risk, Mary Hill, Linnea Fletcher, Wei Hou, Dallin Peterson, Karlee Adams, Dagmar Vitek, Allyn Nakashima, Angela Dunn MMWR / May 25, 2018 / Vol. 67 / No. 20 US Department of Health and Human Services/Centers for Disease Control and Prevention On December 8, 2017, the Utah Poison Control Center (UPCC) notified the Utah Department of Health (UDOH) of reports of emergency department visits associated with reported [...]
Lire la suitePsychiatric Comorbidity of Cannabis Use Disorder David Gorelick In book : "Cannabis Use Disorders", January 2019 DOI : 10.1007/978-3-319-90365-1_13 Abstract : Objective : This chapter reviews the epidemiology and treatment of cannabis use disorder (CUD) with psychiatric comorbidity. Methods : We summarize the findings of English-language epidemiological studies reporting current (past-year) comorbidity and of controlled clinical trials of treatment in which the majority of participants had diagnosed CUD and a specific comorbid disorder. Results : There is substantial CUD comorbidity among community-dwelling adults with major psychiatric disorders: 4–6% for depression, 14% for bipolar disorder, 5% for anxiety disorder, and 16% for schizophrenia. Conversely, there is substantial psychiatric [...]
Lire la suiteOpportunities for cannabis in supportive care in cancer Amber S. Kleckner , Ian R. Kleckner, Charles S. Kamen, Mohamedtaki A. Tejani, Michelle C. Janelsins, Gary R. Morrow and Luke J. Peppone Therapeutic Advances in Medical Oncology, 2019, Vol. 11, 1–29 Doi : 10.1177/1758835919866362 Abstract Cannabis has the potential to modulate some of the most common and debilitating symptoms of cancer and its treatments, including nausea and vomiting, loss of appetite, and pain. However, the dearth of scientific evidence for the effectiveness of cannabis in treating these symptoms in patients with cancer poses a challenge to clinicians in discussing this option with their patients. A review [...]
Lire la suite